Head-to-head dispatch
Semaglutide Online vs VivioMD
Two GLP-1 providers, one scorecard. Both are graded on the same six Desk Score dimensions — here is how they stack up, and which one fits you.
Desk Score
Semaglutide Online is a LegitScript-certified telehealth platform prescribing compounded and brand-name GLP-1/GIP medications nationwide (excluding Alabama).
$199/mo (all doses, compounded) sema · $299/mo (all doses, compounded) tirz · Verified July 5, 2026
Marked down on: No labs or clinical monitoring disclosed — blood work requirements not mentioned anywhere on site
Desk Score
VivioMD is a 50-state telehealth weight-loss program selling compounded semaglutide and compounded tirzepatide — by weekly injection or in an oral form — alongside a brand-name lane, with no price published before the assessment.
Marked down on: No price appears anywhere before the medical assessment — the homepage promises "Transparent Pricing, No Hidden Fees" without printing a figure
FDAWarning letter issued to VivioMD Group LLC dba VivioMD in June 2026. See the FDA warning-letter database.
Semaglutide Online takes this head-to-head with the higher Desk Score, 88/100 (B+) against 64/100 (C) for VivioMD. VivioMD still holds its ground where its strengths line up with yours.
Desk Score, dimension by dimension
Same six measured dimensions for both. The red flag marks the stronger side. See the methodology.
Semaglutide Online
88/100
B+
VivioMD
64/100
C
Price transparency
State access
Molecule range
Onboarding speed
Support responsiveness
Licensing & trust
The spec sheet
| Field | Semaglutide Online | VivioMD |
|---|---|---|
| Semaglutide | $199/mo (all doses, compounded) | Not listed on VivioMD's site (checked August 29, 2026) |
| Tirzepatide | $299/mo (all doses, compounded) | Not listed on VivioMD's site (checked August 29, 2026) |
| Coverage | All 50 states | All 50 states |
| Brand-name | Yes | Yes |
| Oral option | Yes | Yes |
| Best for | LegitScript GLP-1 nationwide ex. AL; compounded sema $199 or tirz $299/mo all-in; financing from $79/mo. | People who want compounded semaglutide or tirzepatide, injected or oral, with free shipping and a refund if a provider declines them — and who do not mind that the price appears only after the assessment. |
| Desk Score | 88/100B+ | 64/100C |
The verdict
Desk pick — Semaglutide OnlineSemaglutide Online takes this head-to-head with the higher Desk Score, 88/100 (B+) against 64/100 (C) for VivioMD. VivioMD still holds its ground where its strengths line up with yours.
Choose Semaglutide Online if…
LegitScript GLP-1 nationwide ex. AL; compounded sema $199 or tirz $299/mo all-in; financing from $79/mo.
$199/mo (all doses, compounded) sema · $299/mo (all doses, compounded) tirz · All 50 states
Choose VivioMD if…
People who want compounded semaglutide or tirzepatide, injected or oral, with free shipping and a refund if a provider declines them — and who do not mind that the price appears only after the assessment.
All 50 states
FDAWarning letter issued to VivioMD Group LLC dba VivioMD in June 2026. See the FDA warning-letter database.
Assume any provider we list may compensate us — we may earn a referral commission at no extra cost to you, and what we file on a provider reads the same either way. Read full breakdowns: Semaglutide Online · VivioMD.
Also here
CoreAge Rx tops every dispatch at 94/100
Whichever of these two you lean toward, the Desk's #1-rated provider outscores them both. The Desk's top dispatch: one price at every dose, both molecules, all 50 states — but the $99 and $149 figures are 12-month plans paid up front, not a monthly bill.
More head-to-heads
- CoreAge Rx vs Semaglutide Online
- CoreAge Rx vs VivioMD
- Semaglutide Online vs Vaylen
- Vaylen vs VivioMD
- RxSpan MD vs Semaglutide Online
- Sesame Care vs VivioMD
Or see the full comparison hub and the complete ranking.
Pricing and verification reflect each provider's public disclosures at last scoring; the Desk Score is our editorial judgment per the methodology. Prices change — confirm on each provider's own site. Not medical advice; see our disclosure.